8DX-32223-04089
3 vaccinations
4 coded responses
26 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site mass — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Small lump at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-06
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Injection site is not red or painful, but is bruisedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-05
- 2021-08-04
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2022-02-05
-
2022-06-01
Survey response — 6 months, dose 3MedDRA: Inflammatory marker increased, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Common cold symptoms currently (ongoing since 11 days ago), have tested neg twice for COVID. Also have had ongoing elevation of inflammation markers for several months.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-01
Survey response — 12 months, dose 3MedDRA: COVID-19, Colon operation, Diverticulitis, Hospitalisation, Hypothyroidism, Large intestine perforation, Menopause, Psoriatic arthropathy, Sepsis, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: I currently have COVID. I had a bad sinus infection. I was also hospitalized for sepsis secondary to colon perforation/diverticulitis, with resultsnt colon resection. Diagnosed with psoriatic arthritis and hypothyroidism as well as menopause.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-12-02
- 2022-12-08
-
2022-12-08
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Small lump at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Injection site is not red or painful, but is bruised
Release 11 — 6 months, dose 3
Symptoms: Common cold symptoms currently (ongoing since 11 days ago), have tested neg twice for COVID. Also have had ongoing elevation of inflammation markers for several months.
Release 12 — 12 months, dose 3
Symptoms: I currently have COVID. I had a bad sinus infection. I was also hospitalized for sepsis secondary to colon perforation/diverticulitis, with resultsnt colon resection. Diagnosed with psoriatic arthritis and hypothyroidism as well as menopause.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Colon operation | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diverticulitis | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Inflammatory marker increased | · | · | ✓ |
| SD | Large intestine perforation | · | · | ✓ |
| SD | Menopause | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Psoriatic arthropathy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sepsis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release